









Mercado
/
Acciones
/
nasdaq-clvt
/

Clarivate PLC

CLVT

3.400USD

+0.160+4.94%

Cierre 10/31, 16:00（ET）Cotizaciones retrasadas 15 min

2.25BCap. mercado

PérdidaP/E TTM



Clarivate PLC

3.400

+0.160+4.94%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Clarivate PLC Compañía

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.

Información de Clarivate PLC



Símbolo de cotizaciónCLVT

Nombre de la empresaClarivate PLC

Fecha de salida a bolsaOct 29, 2018

Director ejecutivoMr. Matitiahu Shem (Matti) Tov

Número de empleados12000

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 29

Dirección70 St. Mary Axe

CiudadLONDON

Bolsa de valoresNYSE Consolidated

PaísUnited Kingdom

Código postalEC3A 8BE

Teléfono442074334000

Sitio Webhttps://clarivate.com/

Símbolo de cotizaciónCLVT

Fecha de salida a bolsaOct 29, 2018

Director ejecutivoMr. Matitiahu Shem (Matti) Tov

Ejecutivos de Clarivate PLC



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Henry Levy

President - Life Sciences and Health care

341.06K

-17.18%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

299.94K

-38.66%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

116.52K

+42.06%

Dr. Wendell E. Pritchett

Independent Director

101.81K

+41.73%

Ms. Valeria Alberola

Independent Director

91.16K

+57.91%

Mr. Kenneth L. Cornick

Director

32.71K

+9.20%

Mr. Jane Okun Bomba, CPA

Independent Director

Ms. Suzanne Heywood

Independent Director

Mr. Usama N. Cortas

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Bar Veinstein

President - Academia and Government

729.15K

+150.40%

Mr. Henry Levy

President - Life Sciences and Health care

341.06K

-17.18%

Mr. Jonathan Mark Collins

Chief Financial Officer, Executive Vice President

299.94K

-38.66%

Dr. Saurabh Saha, M.D., Ph.D.

Independent Director

116.52K

+42.06%

Dr. Wendell E. Pritchett

Independent Director

101.81K

+41.73%

Ms. Valeria Alberola

Independent Director

91.16K

+57.91%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Subscription revenues

405.70M

65.29%

Re-occurring revenues

108.90M

17.52%

Transactional revenues

106.80M

17.19%

Por regiónUSD

Nombre

Ganancia

Proporción

Americas

331.90M

53.41%

Europe/ Middle East /Africa

164.90M

26.54%

Asia Pacific

124.60M

20.05%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Subscription revenues

405.70M

65.29%

Re-occurring revenues

108.90M

17.52%

Transactional revenues

106.80M

17.19%

Estadísticas de accionistas

Actualizado: vie., 15 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

Leonard Green & Partners, L.P.

17.64%

Clarkston Capital Partners, LLC

10.59%

Giovanni Agnelli B V

10.17%

Impactive Capital LP

6.50%

Onex Corporation

6.34%

Otro

48.76%

Accionistas

Proporción

Leonard Green & Partners, L.P.

17.64%

Clarkston Capital Partners, LLC

10.59%

Giovanni Agnelli B V

10.17%

Impactive Capital LP

6.50%

Onex Corporation

6.34%

Otro

48.76%

Tipos de accionistas

Accionistas

Proporción

Private Equity

31.46%

Investment Advisor

29.18%

Hedge Fund

16.43%

Investment Advisor/Hedge Fund

10.60%

Holding Company

10.17%

Corporation

5.76%

Pension Fund

1.79%

Research Firm

1.32%

Individual Investor

1.09%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

588

605.96M

91.61%

-105.46M

2025Q2

648

749.09M

111.46%

-147.42M

2025Q1

695

750.51M

109.86%

-167.62M

2024Q4

712

766.77M

110.84%

-166.20M

2024Q3

726

765.53M

108.25%

-158.23M

2024Q2

741

760.08M

105.78%

-120.39M

2024Q1

752

730.14M

108.67%

-137.39M

2023Q4

783

725.50M

108.90%

-179.38M

2023Q3

791

741.16M

111.25%

-79.71M

2023Q2

796

712.25M

105.35%

-100.17M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Leonard Green & Partners, L.P.

116.67M

17.36%

Jun 30, 2025

Clarkston Capital Partners, LLC

70.03M

10.42%

-4.50M

-6.03%

Jun 30, 2025

Giovanni Agnelli B V

67.29M

10.01%

Jun 30, 2025

Impactive Capital LP

43.03M

6.4%

Jun 30, 2025

Onex Corporation

41.92M

6.24%

-938.25K

-2.19%

Mar 10, 2025

Selige Co-Investor Pooling SCSp

38.09M

5.67%

Mar 10, 2025

Partners Group AG

25.58M

3.81%

Jun 30, 2025

Cambridge Information Group, Inc.

23.90M

3.56%

+290.94K

+1.23%

Mar 10, 2025

Dimensional Fund Advisors, L.P.

21.07M

3.13%

+4.48M

+26.98%

Jun 30, 2025

Citadel Advisors LLC

17.88M

2.66%

+5.11M

+40.04%

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

AGF US Market Neutral Anti-Beta Fund

0.52%

Avantis US Small Cap Value ETF

0.2%

WisdomTree US MidCap Fund

0.19%

JPMorgan US Value Factor ETF

0.17%

DFA Dimensional US Small Cap Value ETF

0.16%

John Hancock Multifactor Small Cap ETF

0.13%

Nuveen ESG Small-Cap ETF

0.12%

BNY Mellon US Small Cap Core Equity ETF

0.09%

Strive Small-Cap ETF

0.08%

Avantis US Small Cap Equity ETF

0.07%

AGF US Market Neutral Anti-Beta Fund

Proporción0.52%

Avantis US Small Cap Value ETF

Proporción0.2%

WisdomTree US MidCap Fund

Proporción0.19%

JPMorgan US Value Factor ETF

Proporción0.17%

DFA Dimensional US Small Cap Value ETF

Proporción0.16%

John Hancock Multifactor Small Cap ETF

Proporción0.13%

Nuveen ESG Small-Cap ETF

Proporción0.12%

BNY Mellon US Small Cap Core Equity ETF

Proporción0.09%

Strive Small-Cap ETF

Proporción0.08%

Avantis US Small Cap Equity ETF

Proporción0.07%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

